Search results for "PPAR"

showing 10 items of 1686 documents

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe…

2021

Background: ANDHI was done to assess the efficacy of benralizumab, including onset of effect and impact on health-related quality of life (HRQOL), exacerbation rate, lung function, and nasal polyposis symptoms. Methods: This phase 3b, randomised, double-blind, parallel-group, placebo-controlled ANDHI study was completed in adults (aged 18–75 years) with severe eosinophilic asthma with at least 2 exacerbations in the previous year, despite high-dose inhaled corticosteroid plus additional controllers, screening blood eosinophil counts of at least 150 cells per μL, and an Asthma Control Questionnaire 6 (ACQ-6) score of 1·5 or more. Patients who met eligibility criteria were randomly assigned (…

Pulmonary and Respiratory MedicineSpirometryAdultMalemedicine.medical_specialtyExacerbation[SDV]Life Sciences [q-bio]PopulationSettore MED/10 - Malattie Dell'Apparato RespiratorioPlaceboAntibodies Monoclonal Humanized03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodInternal medicinemedicineHumans030212 general & internal medicineAnti-Asthmatic AgentsPatient Reported Outcome MeasureseducationSinusitisAsthmaeducation.field_of_studymedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseBenralizumabAsthma3. Good healthEosinophils030228 respiratory systemchemistryAsthma Control QuestionnaireSpirometryDisease ProgressionQuality of LifeFemalebusiness
researchProduct

Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients.

2003

Questionnaires are the most used subjective instrument of measurement in respiratory epidemiology. The standardisation of the questionnaires aims to limit bias by maximising validity and reliability, and comparability. Within the European Union project BIOMED1, a compendium of respiratory standard questionnaires (CORSQ) was developed for adults covering 18 topics from general information to early life events, through environmental risk factors and respiratory symptoms and diseases. Reliable spirometry data needs a rigorous quality control programme, as in the "Salute Respiratoria nell'Anziano" (Sa.R.A.) project, Italian for "Respiratory Health in the Elderly". Reproducibility rates were 95.…

Pulmonary and Respiratory MedicineSpirometryAdultMalemedicine.medical_specialtypeak expiratory flowRespiratory Tract DiseasesMEDLINEValidityPeak Expiratory Flow RateSettore MED/10 - Malattie Dell'Apparato RespiratorioElderlyReference ValuesRisk FactorsAir PollutionSurveys and QuestionnairesEpidemiologyElderly peak expiratory flow questionnaires reference values spirometryMedicinemedia_common.cataloged_instanceHumansReference ValueEuropean unionRespiratory Tract DiseaseReliability (statistics)media_commonAgedmedicine.diagnostic_testbusiness.industryRisk FactorRespiratory diseaseCognitionquestionnairesmedicine.diseaseEpidemiologic StudieSurgeryEpidemiologic StudiesSpirometryPhysical therapyFemalebusinessHumanThe European respiratory journal. Supplement
researchProduct

Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD

2013

Expressing forced expiratory volume in 1 s (FEV1) as % predicted relies on the assumption of proportional variability and generalisability of prediction equations that may be unrealistic, especially for elderly people. We evaluated the prognostic implications of alternative ways of expressing FEV1. We enrolled 318 patients with chronic obstructive pulmonary disease (COPD) and 475 controls in the Salute Respiratoria nell'Anziano (SARA) study. The risk for 5-, 10- and 15-year mortality associated with FEV1 was studied by expressing FEV1 % pred, standardised by height cubed (FEV1 · Ht(-3)) and as a multiple of the sex-specific first percentile (FEV1 quotient (FEV1Q)). In the group with COPD, t…

Pulmonary and Respiratory MedicineSpirometryMalemedicine.medical_specialtyPediatricsPercentilePrognosiPulmonary diseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioRate ratioPulmonary Disease Chronic ObstructiveElderly populationInternal medicineForced Expiratory VolumeHumansMedicineElderly peopleRespiratory Function TestAgedCOPDmedicine.diagnostic_testbusiness.industryRespiratory Function Tests; Spirometry; Humans; Treatment Outcome; Prognosis; Case-Control Studies; Aged; Middle Aged; Forced Expiratory Volume; Male; Female; Pulmonary Disease Chronic ObstructiveCase-control studyrespiratory systemMiddle AgedPrognosismedicine.diseaseRespiratory Function Testsrespiratory tract diseasesTreatment OutcomeSpirometryCase-Control StudiesFemalebusinessCase-Control StudieHuman
researchProduct

Small airways function and molecular markers in exhaled air in mild asthma.

2005

Background: Several studies suggest that the periphery of the lung is the major site of inflammation in asthma. Fractional exhaled nitric oxide (FeNO) and 8-isoprostane have been proposed as biomarkers of inflammation and oxidative stress. We therefore hypothesised that small airway dysfunction in asthma is of inflammatory origin that can be detected by molecular markers in exhaled air. To test this hypothesis, we examined the relationship of FeNO and 8-isoprostane in exhaled air with small airways function as assessed by the single breath nitrogen test. Methods: Sixteen patients (14 women) with mild atopic asthma (forced expiratory volume in 1 second >80% predicted) of mean (SD) age 23.0 (…

Pulmonary and Respiratory MedicineSpirometrySmall airwayAdultMalemedicine.medical_specialtyVital CapacityEnzyme-Linked Immunosorbent AssaySettore MED/10 - Malattie Dell'Apparato RespiratorioDinoprostNitric OxideGastroenterologyNitric oxidechemistry.chemical_compoundInternal medicineForced Expiratory VolumemedicineHumansExhaled breath condensateBronchitisAsthmaLungmedicine.diagnostic_testbusiness.industryRespiratory diseaserespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesmedicine.anatomical_structureCross-Sectional StudieschemistryExhaled nitric oxideImmunologyBronchitisFemalebusinessBiomarkersThorax
researchProduct

Validation of FEV6 in the elderly: correlates of performance and repeatability.

2007

BACKGROUND: Forced expiratory volume in 6 s (FEV6) has been proposed as a more easily measurable parameter than forced vital capacity (FVC) to diagnose airway disease using spirometry. A study was undertaken to estimate FEV6 repeatability, to identify correlates of a good quality FEV6 measurement and of volumetric differences between FEV6 and FVC in elderly patients. METHODS: 1531 subjects aged 65-100 years enrolled in the SA.R.A project (a cross-sectional multicentre non-interventional study) were examined. FEV6 was measured on volume-time curves that achieved satisfactory start-of-test and end-of-test criteria. Correlates of FEV6 achievement were assessed by logistic regression. RESULTS: …

Pulmonary and Respiratory MedicineSpirometryVital capacitymedicine.medical_specialtyCross-sectional studyPopulationVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionFEV1/FVC ratioForced Expiratory VolumemedicineHumanseducationAgedAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryReproducibility of ResultsBronchial DiseasesRepeatabilityrespiratory systemAirway obstructionlung function agingmedicine.diseaserespiratory tract diseasesCross-Sectional StudiesPhysical therapybusiness
researchProduct

Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study

2019

BACKGROUND: Small airways dysfunction (SAD) is well recognised in asthma, yet its role in the severity and control of asthma is unclear. This study aimed to assess which combination of biomarkers, physiological tests, and imaging markers best measure the presence and extent of SAD in patients with asthma.METHODS: In this baseline assessment of a multinational prospective cohort study (the Assessment of Small Airways Involvement in Asthma [ATLANTIS] study), we recruited participants with and without asthma (defined as Global Initiative for Asthma severity stages 1-5) from general practices, the databases of chest physicians, and advertisements at 29 centres across nine countries (Brazil, Chi…

Pulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtySocio-culturaleSettore MED/10 - Malattie Dell'Apparato RespiratorioDISEASE03 medical and health sciences0302 clinical medicineQuality of lifeHYPERRESPONSIVENESSInternal medicineSeverity of illnessMedicine030212 general & internal medicineProspective cohort studyAsthmamedicine.diagnostic_testbusiness.industryasthmamedicine.diseaseNitrogen washoutrespiratory tract diseasessmall airways dysfunctionLUNG-MECHANICSSEVERITY030228 respiratory systemSalbutamolVENTILATION HETEROGENEITYbiomarkerAsthma; small airways dysfunctionbusinessmedicine.drugCohort study
researchProduct

Why chronic obstructive pulmonary disease patients get so short of breath with limited activity

2013

equivalence despite the simplicity of MPT versus CPET as a surrogate to detect DH in COPD patients, by measuring the decrease in inspiratory capacity to reflect the increase in end-expiratory lung volume [3] . Lahaije et al. [2] have investigated whether DH as measured in the laboratory settings (CPET and MPT) reflects DH that is associated with dyspnea-limiting ADL. The authors conclude that both CPET and MPT can serve as a screening tool to identify patients who are susceptible to develop DH during ADL. In practice, MPT is simpler to obtain and is an inexpensive surrogate. However, sensitivity of MPT may not be optimal. When DH does not occur during CPET, it is unlikely to occur during AD…

Pulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtyWeaknessSettore MED/10 - Malattie Dell'Apparato RespiratorioTachypneaPulmonary Disease Chronic ObstructiveActivities of Daily LivingmedicineHumansLung volumesIntensive care medicineDynamic hyperinflationCOPDLungmedicine.diagnostic_testbusiness.industryAirway obstructionmedicine.diseaserespiratory tract diseasesmedicine.anatomical_structureExercise Testmedicine.symptombusinessExercise Test; Humans; Activities of Daily Living; Pulmonary Disease Chronic ObstructiveHuman
researchProduct

Inhaler mishandling remains common in real life and is associated with reduced disease control

2011

SummaryProper inhaler technique is crucial for effective management of asthma and COPD. This multicentre, cross-sectional, observational study investigates the prevalence of inhaler mishandling in a large population of experienced patients referring to chest clinics; to analyze the variables associated with misuse and the relationship between inhaler handling and health-care resources use and disease control.We enrolled 1664 adult subjects (mean age 62 years) affected mostly by COPD (52%) and asthma (42%). Respectively, 843 and 1113 patients were using MDIs and DPIs at home; of the latter, the users of Aerolizer®, Diskus®, HandiHaler® and Turbuhaler® were 82, 467, 505 and 361.We have a tota…

Pulmonary and Respiratory MedicineVital capacitymedicine.medical_specialtyCross-sectional studyPopulationSettore MED/10 - Malattie Dell'Apparato RespiratorioMDIPulmonary Disease Chronic ObstructiveFEV1/FVC ratioPatient Education as TopicAdministration InhalationInhaler techniquemedicineCOPDHumansMetered Dose InhalerseducationAsthmaCOPDeducation.field_of_studybusiness.industryInhalerPatient educationMiddle Agedmedicine.diseaseAsthmaDry-powder inhalerasthma therapy deviceDPISelf CareCross-Sectional StudiesEmergency medicinePhysical therapyPatient ComplianceFemalebusinessRespiratory Medicine
researchProduct

Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors

2019

High blood pressure (BP) and non-dipping 24-hour BP profile may help to predict BP decrease after obstructive sleep apnoea treatment by CPAP. However, specific, highly reproducible traits associated with BP responsiveness to CPAP must still be identified.http://bit.ly/2LbS4uV

Pulmonary and Respiratory Medicinearterial hypertensionmedicine.medical_specialtymedicine.medical_treatmentBlood PressureSettore MED/10 - Malattie Dell'Apparato Respiratorioblood pressure dipping03 medical and health sciences0302 clinical medicineText miningCPAPInternal medicinemedicineHumans030212 general & internal medicineContinuous positive airway pressureobstructive sleep apneatherapySleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryBlood Pressure DeterminationSleep in non-human animalsnervous system diseasesrespiratory tract diseasesBlood pressure030228 respiratory systemHypertensionCardiologybusinessHuman
researchProduct

Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics

2019

Background: Healthcare decisions made on the basis of insufficient evidence may potentially have ineffective or even harmful consequences. The proportion of older ages (over 65 years) in randomized controlled trials (RCTs) for severe asthma is not enough to establish whether anti-IL-5/IL-5R therapies are equally effective in the elderly as in younger subjects. Methods: In order to assess the relationship between age and the efficacy of anti-IL-5 monoclonal antibodies (mABs) with respect to the risk of exacerbations and changes in FEV1, a meta-regression analysis via random-effect method was carried out by plotting the effect estimates (outcome variables) resulting from the pairwise meta-ana…

Pulmonary and Respiratory Medicinelcsh:Immunologic diseases. AllergymABs monoclonal antibodiesSevere asthmamedicine.medical_specialtyExacerbationSettore MED/10 - Malattie dell'Apparato RespiratorioImmunologyPopulationEosinophilArticlelaw.invention03 medical and health scienceschemistry.chemical_compoundAge0302 clinical medicineReslizumabRandomized controlled triallawInternal medicineImmunology and AllergyMedicine030223 otorhinolaryngologyeducationAsthmaEos eosinophilseducation.field_of_studybusiness.industryyrs yearsAnti-IL5medicine.diseaseBenralizumabEosinophilsRCTs Randomized Controlled TrialsClinical trial030228 respiratory systemchemistryTherapybusinesslcsh:RC581-607Mepolizumabmedicine.drug
researchProduct